Ovarian Granulosa Cell Tumor clinical trials at UCLA
1 in progress, 0 open to eligible people
Sorry, in progress, not accepting new patients
This phase 2 clinical trial will study the effectiveness of nirogacestat in ovarian granulosa cell tumors (OvGCTs). Nirogacestat is a gamma secretase inhibitor (GSI) which is hypothesized to decrease the growth and activity of ovarian granulosa tumors.
Los Angeles, California and other locations